An explosive study for metastatic squamous lung cancer with fist-line treatment of recombinant human endostatin, PD-1 inhibitor and GP regimens
Latest Information Update: 30 Jul 2020
At a glance
- Drugs BMS 936559 (Primary) ; Endostatin (Primary) ; TMBC (Primary)
- Indications Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 30 Jul 2020 New trial record